XML 71 R53.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Tempus Agreement - Additional Information (Details) $ / shares in Units, $ in Thousands |  |  | 12 Months Ended
--- | --- | --- | ---
Nov. 28, 2023 USD ($) $ / shares shares | Nov. 25, 2023 USD ($) | Dec. 31, 2023 USD ($) Warrants
Tempus Warrants |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |
Proceeds from issuance of Warrants |  |  | $ 6,000
Tempus Agreement |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |
Market Development Fees | $ 6,000 |  | 6,000
Activation Fees |  | $ 3,000 | 3,000
First milestone fees payment upon achivement of specified clinical validations |  | 3,000 |
Second milestone fees payment subject to achieving two additional clinicial validations |  | 6,000 |
Fair market value of promotional and commercialization services |  | 9,600 |
First milestone fee |  |  | $ 3,000
Number of warrants | Warrants |  |  | 2
Initial fair value | 6,900 |  |
Proceeds from issuance of Warrants | 6,000 |  |
Increase in fair value of warrants |  |  | $ 3,100
Tempus Agreement | Other Income (Expense) |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |
Warrant losses | $ 900 |  | 900
Warrant expense recognized |  |  | 4,000
Tempus Agreement | First Warrant |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |
Warrant exercise price per share | $ / shares | $ 1.5 |  |
Warrant expiration date | Dec. 31, 2024 |  |
Tempus Agreement | Tempus Warrants |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |
Warrant exercise price per share | $ / shares | $ 2.5 |  |
Warrant expiration date | Dec. 31, 2025 |  |
Proceeds from issuance of Warrants |  |  | $ 6,000
Tempus Agreement | Maximum |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |
Market Development Fees |  | $ 12,000 |
Percentage of its gross revenues attributable to such license |  |  | 20.00%
Tempus Agreement | Maximum | First Warrant |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |
Warrant issued to purchase stock | shares | 4,609,400 |  |
Tempus Agreement | Maximum | Tempus Warrants |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |
Warrant issued to purchase stock | shares | 4,609,400 |  |
Tempus Agreement | Minimum |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |
Percentage of its gross revenues attributable to such license |  |  | 10.00%

X
- Definition Activation fees + References No definition available. + Details
Name: | psnl_ActivationFees
Namespace Prefix: | psnl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Class of warrant or right, expense recognized. + References No definition available. + Details
Name: | psnl_ClassOfWarrantOrRightExpenseRecognized
Namespace Prefix: | psnl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair market value of promotional and commercialization services + References No definition available. + Details
Name: | psnl_FairMarketValueOfPromotionalAndCommercializationServices
Namespace Prefix: | psnl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition First milestone fee. + References No definition available. + Details
Name: | psnl_FirstMilestoneFee
Namespace Prefix: | psnl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition First milestone payments upon achievement of specified clinical validations + References No definition available. + Details
Name: | psnl_FirstMilestonePaymentsUponAchievementOfSpecifiedClinicalValidations
Namespace Prefix: | psnl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Increase (decrease) in fair value of warrants. + References No definition available. + Details
Name: | psnl_IncreaseDecreaseInFairValueOfWarrants
Namespace Prefix: | psnl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Initial fair value of warrants. + References No definition available. + Details
Name: | psnl_InitialFairValueOfWarrants
Namespace Prefix: | psnl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of Warrents + References No definition available. + Details
Name: | psnl_NumberOfWarrents
Namespace Prefix: | psnl_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of its gross revenues attributable to such license + References No definition available. + Details
Name: | psnl_PercentageOfItsGrossRevenuesAttributableToSuchLicense
Namespace Prefix: | psnl_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Second Milestone Fees Payable Subject to Achieving Two Additial Clinical Validations + References No definition available. + Details
Name: | psnl_SecondMilestoneFeesPayableSubjectToAchievingTwoAdditialClinicalValidations
Namespace Prefix: | psnl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 25 -Paragraph 13 -SubTopic 10 -Topic 480 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13 + Details
Name: | us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received for fees during the current period. This element excludes cash proceeds from license fees. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_ProceedsFromFeesReceived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=psnl_TempusWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=psnl_TempusAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=psnl_FirstWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |